ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
efr999
|
160 |
84K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
84K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
efr999
|
10K |
5.0M |
8 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
10K
|
5.0M
|
8
|
|
ASX - By Stock
|
SP1 |
Re:
Value
|
|
efr999
|
37 |
22K |
0 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
37
|
22K
|
0
|
|
ASX - By Stock
|
MMI |
Re:
price target 32 cent
|
|
efr999
|
4 |
1.8K |
1 |
16/02/15 |
16/02/15 |
ASX - By Stock
|
4
|
1.8K
|
1
|
|
ASX - By Stock
|
BRG |
Re:
adding to the shrill shrieks
|
|
efr999
|
30 |
5.9K |
0 |
07/03/13 |
07/03/13 |
ASX - By Stock
|
30
|
5.9K
|
0
|
|
ASX - By Stock
|
TPI |
Re:
scenario analysis highlights return potential
|
|
efr999
|
25 |
3.5K |
1 |
22/01/13 |
22/01/13 |
ASX - By Stock
|
25
|
3.5K
|
1
|
|